acyclovir NDC 72162-1724

Product information

Brand name (proprietary)

acyclovir

Generic name (nonproprietary)

acyclovir

Active ingredients

Acyclovir — 800 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Bryant Ranch Prepack

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 077309

Marketing start

Mar 13, 2006

Marketing end

Dec 31, 2026

Other FDA classes

DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)

Identifiers

Product ID 72162-1724_a45392d2-5725-47dc-a6c5-50a98f93031aSPL ID a45392d2-5725-47dc-a6c5-50a98f93031aSPL set ID a7fd298b-3914-4316-8484-2d3ae188221aRxCUI 197313UNII X4HES1O11F

Pharmacologic class

Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162172400 followed by a unit qualifier and the quantity Copy

Package 72162-1724-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 077309

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.